BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1554 related articles for article (PubMed ID: 31558455)

  • 1. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
    Haebich KM; Pride NA; Walsh KS; Chisholm A; Rouel M; Maier A; Anderson V; Barton B; Silk T; Korgaonkar M; Seal M; Lami F; Lorenzo J; Williams K; Dabscheck G; Rae CD; Kean M; North KN; Payne JM
    BMJ Open; 2019 Sep; 9(9):e030601. PubMed ID: 31558455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineating the autistic phenotype in children with neurofibromatosis type 1.
    Chisholm AK; Haebich KM; Pride NA; Walsh KS; Lami F; Ure A; Maloof T; Brignell A; Rouel M; Granader Y; Maier A; Barton B; Darke H; Dabscheck G; Anderson VA; Williams K; North KN; Payne JM
    Mol Autism; 2022 Jan; 13(1):3. PubMed ID: 34983638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Autism Spectrum Disorder symptoms in children with neurofibromatosis type 1.
    Plasschaert E; Descheemaeker MJ; Van Eylen L; Noens I; Steyaert J; Legius E
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jan; 168B(1):72-80. PubMed ID: 25388972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social Function and Autism Spectrum Disorder in Children and Adults with Neurofibromatosis Type 1: a Systematic Review and Meta-Analysis.
    Chisholm AK; Anderson VA; Pride NA; Malarbi S; North KN; Payne JM
    Neuropsychol Rev; 2018 Sep; 28(3):317-340. PubMed ID: 30097761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.
    Morotti H; Mastel S; Keller K; Barnard RA; Hall T; O'Roak BJ; Fombonne E
    Dev Med Child Neurol; 2021 Feb; 63(2):226-232. PubMed ID: 32406525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autism spectrum disorder profile in neurofibromatosis type I.
    Garg S; Plasschaert E; Descheemaeker MJ; Huson S; Borghgraef M; Vogels A; Evans DG; Legius E; Green J
    J Autism Dev Disord; 2015 Jun; 45(6):1649-57. PubMed ID: 25475362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning.
    Plasschaert E; Van Eylen L; Descheemaeker MJ; Noens I; Legius E; Steyaert J
    Am J Med Genet B Neuropsychiatr Genet; 2016 Apr; 171B(3):348-62. PubMed ID: 26773288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.
    Walsh KS; Vélez JI; Kardel PG; Imas DM; Muenke M; Packer RJ; Castellanos FX; Acosta MT
    Dev Med Child Neurol; 2013 Feb; 55(2):131-138. PubMed ID: 23163951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of epilepsy on autistic symptom severity assessed by the social responsiveness scale in children with autism spectrum disorder.
    Ko C; Kim N; Kim E; Song DH; Cheon KA
    Behav Brain Funct; 2016 Jun; 12(1):20. PubMed ID: 27350381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).
    Morris SM; Acosta MT; Garg S; Green J; Huson S; Legius E; North KN; Payne JM; Plasschaert E; Frazier TW; Weiss LA; Zhang Y; Gutmann DH; Constantino JN
    JAMA Psychiatry; 2016 Dec; 73(12):1276-1284. PubMed ID: 27760236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
    Lorenzo J; Barton B; Arnold SS; North KN
    J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the natural history and prognostic factors of ASD in children: the multicEntric Longitudinal study of childrEN with ASD - the ELENA study protocol.
    Baghdadli A; Miot S; Rattaz C; Akbaraly T; Geoffray MM; Michelon C; Loubersac J; Traver S; Mortamais M; Sonié S; Pottelette J; Robel L; Speranza M; Vesperini S; Maffre T; Falissard B; Picot MC;
    BMJ Open; 2019 Jun; 9(6):e026286. PubMed ID: 31221874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 1 and autism spectrum disorder.
    Garg S; Green J; Leadbitter K; Emsley R; Lehtonen A; Evans DG; Huson SM
    Pediatrics; 2013 Dec; 132(6):e1642-8. PubMed ID: 24190681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineating Visual Habituation Profiles in Preschoolers with Neurofibromatosis Type 1 and Autism Spectrum Disorder: A Cross-Syndrome Study.
    Hocking DR; Sun X; Haebich K; Darke H; North KN; Vivanti G; Payne JM
    J Autism Dev Disord; 2024 May; 54(5):1998-2011. PubMed ID: 36877426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening children with neurofibromatosis type 1 for autism spectrum disorder.
    Tinker J; Carbone PS; Viskochil D; Mathiesen A; Ma KN; Stevenson DA
    Am J Med Genet A; 2014 Jul; 164A(7):1706-12. PubMed ID: 24715629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.
    Pride NA; Barton B; Hutchins P; Coghill DR; Korgaonkar MS; Hearps SJC; Rouel M; Malarbi S; North KN; Payne JM
    BMJ Open; 2018 Aug; 8(8):e021800. PubMed ID: 30166301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).
    Eijk S; Mous SE; Dieleman GC; Dierckx B; Rietman AB; de Nijs PFA; Ten Hoopen LW; van Minkelen R; Elgersma Y; Catsman-Berrevoets CE; Oostenbrink R; Legerstee JS
    J Autism Dev Disord; 2018 Jul; 48(7):2278-2285. PubMed ID: 29423604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: evidence for clinical trial outcomes.
    Payne JM; Walsh KS; Pride NA; Haebich KM; Maier A; Chisholm A; Glad DM; Casnar CL; Rouel M; Lorenzo J; Del Castillo A; North KN; Klein-Tasman B
    Dev Med Child Neurol; 2020 Jul; 62(7):813-819. PubMed ID: 32181506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early development of infants with neurofibromatosis type 1: a case series.
    Kolesnik AM; Jones EJH; Garg S; Green J; Charman T; Johnson MH;
    Mol Autism; 2017; 8():62. PubMed ID: 29204259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social functioning and facial expression recognition in children with neurofibromatosis type 1.
    Allen T; Willard VW; Anderson LM; Hardy KK; Bonner MJ
    J Intellect Disabil Res; 2016 Mar; 60(3):282-93. PubMed ID: 26805654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.